Pictet Asset Management (Switzerland)’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$30.1M Buy
2023
Q1
$34.9M Buy
2022
Q4
$11.7M Buy
2022
Q3
$10.2M Buy
2022
Q2
$8.55M Buy
2022
Q1
$8.05M Sell
2021
Q4
$10.3M Sell
2021
Q3
$8.59M Buy